Dosing of porcine surfactant: Effect on kinetics and gas exchange in respiratory distress syndrome

Pediatrics

Volumn 124, Issue 5, 2009, Pages

  Cogo, Paola Elisa ^a   Facco, Maddalena ^a   Simonato, Manuela ^a   Verlato, Giovanna ^a   Rondina, Clementina ^b   Baritussio, Aldo ^a   Toffolo, Gianna Maria ^a   Carnielli, Virgilio Paolo ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Isotopes; Low birth weight infants; Pulmonary surfactant; Respiratory distress syndrome

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PORACTANT; SURFACTANT;

AIRWAY PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; DRUG DOSE COMPARISON; DRUG HALF LIFE; GAS EXCHANGE; HUMAN; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; NEWBORN; OXYGENATION; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

BIOLOGICAL PRODUCTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TRACHEA;

EID: 70350516068     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-0126     Document Type: Article

References (40)

1. Rebello CM, Jobe AH, Eisele JW, Ikegami M. Alveolar and tissue surfactant pool sizes in humans. AmJ Respir Crit Care Med. 1996;154(3): 625-628 (Pubitemid 26327282)
2. Jobe AH, Ikegami M. Protein permeability abnormalities in the preterm. In: Effros RM, Chang HK, eds. Lung Biology in Health and Disease: Fluid and Solute Transport in the Airspaces of the Lung. New York, NY: Marcel Dekker; 1994:335-355
3. Ikegami M, Adams FH, Towers B, Osher AB. The quantity of natural surfactant necessary to prevent the respiratory distress syndrome in premature lambs. Pediatr Res. 1980;14(9): 1082-1085 (Pubitemid 10059026)
4. Pettenazzo A, Jobe AH, Ikegami M, Rider E, Seidner SR, Yamada T. Cumulative effects of repeated surfactant treatments in the rabbit. Exp Lung Res. 1990;16(2):131-143 (Pubitemid 20134586)
5. Alvarez FJ, Alfonso LF, Gastiasoro E, Lopez-Heredia J, Arnaiz A, Valls-i-Soler A. The effects of multiple small doses of exogenous surfactant on experimental respiratory failure induced by lung lavage in rats. Acta Anaesthesiol Scand. 1995;39(7):970-974
6. Halliday HL, Tarnow-Mordi WO, Corcoran JD, Patterson CC. Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 Trial). Arch Dis Child. 1993;69(3 Spec No):276-280
7. Speer CP, Robertson B, Curstedt T, et al. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics. 1992; 89(1):13-20
8. Speer CP, Gefeller O, Groneck P, et al. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed. 1995;72(1):F8-F13
9. Walti H, Relier JP, Huon C, et al. Treatment of severe hyaline membrane disease with a single dose of natural exogenous surfactant of porcine origin: a randomized trial: immediate effects and outcome at 28 days of life [in French]. Arch Fr Pediatr. 1990;47(5):329-334 (Pubitemid 20188419)
10. Walti H, Paris-Llado J, Breart G, Couchard M. Porcine surfactant replacement therapy in newborns of 25-31 weeks' gestation: a randomized, multicentre trial of prophylaxis versus rescue with multiple low doses. Acta Paediatr. 1995;84(8):913-921
11. Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol. 2004;21(3):109-119 (Pubitemid 38506904)
12. Dunn MS, Shennan AT, Possmayer F. Single-versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome. Pediatrics. 1990;86(4):564-571
13. Baroutis G, Kaleyias J, Liarou T, Papathoma E, Hatzistamatiou Z, Costalos C. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr. 2003;162(7- 8): 476-480 (Pubitemid 36904269)
14. Malloy CA, Nicoski P, Muraskas JK. A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome. Acta Paediatr. 2005;94(6):779-784
15. Halliday HL. History of surfactant from 1980. Biol Neonate. 2005;87(4):317-322
16. Soll R, Ozek E. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2009; (1):CD000141
17. Kattwinkel J, Bloom BT, Delmore P, et al. High versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome. Pediatrics. 2000;106(2):282-288 (Pubitemid 30636396)
18. Hallman M, Merritt TA, Pohjavuori M, Gluck L. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospho-lipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res. 1986;20(12):1228-1235 (Pubitemid 17209108)
19. Griese M, Dietrich P, Reinhardt D. Pharmaco-kinetics of bovine surfactant in neonatal respiratory distress syndrome. Am J Respir Crit Care Med. 1995;152(3):1050-1054
20. Torresin M, Zimmermann LJ, Cogo PE, et al. Exogenous surfactant kinetics in infant respiratory distress syndrome: a novel method with stable isotopes. Am J Respir Crit Care Med. 2000;161(5):1584-1589 (Pubitemid 30329032)
21. Jones PJ, Leatherdale ST. Stable isotopes in clinical research: safety reaffirmed. Clin Sci (Lond). 1991;80(4):277-280
22. Thome U, Topfer A, Schaller P, Pohlandt F. Comparison of lung volume measurements by antero-posterior chest X-ray and the SF6 washout technique in mechanically ventilated infants. Pediatr Pulmonol. 1998;26(4):265-272 (Pubitemid 28492288)
23. Ikegami M, Jobe A, Duane G. Liposomes of dipalmitoylphosphatidylcholine associate with natural surfactant. Biochim Biophys Acta. 1985;835(2):352-359 (Pubitemid 15066075)
24. Sweet D, Bevilacqua G, Carnielli V, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome. J Perinat Med. 2007;35(3):175-186 (Pubitemid 46700981)
25. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911-917
26. Mason RJ, Nellenbogen J, Clements JA. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res. 1976;17(3): 281-284
27. Christie W. Gas Chromatography and Lipids: A Practical Guide. Ayr, Scotland: Oily Press; 1989: 64-84
28. Carnielli VP, Pederzini F, Vittorangeli R, et al. Plasma and red blood cell fatty acid of very low birth weight infants fed exclusively with expressed preterm human milk. Pediatr Res. 1996;39(4):671-679 (Pubitemid 26128156)
29. Cobelli C, Toffolo G. Constant specific activity input allows reconstruction of endogenous glucose concentration in non-steady state. Am J Physiol. 1990;258(6):E1037-E1040 (Pubitemid 20210388)
30. Cobelli C, Toffolo G, Foster D. Tracer-to-tracee ratio for analysis of stable isotope tracer data: link with radioactive kinetic formalism. Am J Physiol. 1992;262(6):E968-E975
31. Glatz T, Ikegami M, Jobe A. Metabolism of exogenously administered natural surfactant in the newborn lamb. Pediatr Res. 1982;16(9): 711-715 (Pubitemid 12046913)
32. Ikegami M, Jobe A, Yamada T, et al. Surfactant metabolism in surfactant-treated preterm ventilated lambs. J Appl Physiol. 1989;67(1): 429-437 (Pubitemid 19196501)
33. Jobe AH, Ikegami M, Seidner SR, Pettenazzo A, Ruffini L. Surfactant phosphatidylcholine metabolism and surfactant function in preterm, ventilated lambs. Am Rev Respir Dis. 1989; 139(2):352-359 (Pubitemid 19057407)
34. Kramer BW, Ikegami M, Jobe AH. Surfactant phospholipid catabolic rate is pool size dependent in mice. Am J Physiol Lung Cell Mol Physiol. 2000;279(5):L842-L848 (Pubitemid 30952001)
35. Seidner SR, Jobe AH, Ruffini L, Ikegami M, Pettenazzo A. Recovery of treatment doses of surfactants from the lungs and vascular compartments of mechanically ventilated premature rabbits. Pediatr Res. 1989;25(4): 423-428 (Pubitemid 19099819)
36. Cogo PE, Zimmermann LJ, Meneghini L, et al. Pulmonary surfactant disaturated-phosphatidylcholine (DSPC) turnover and pool size in newborn infants with congenital diaphragmatic hernia (CDH). Pediatr Res. 2003; 54(5):653-658 (Pubitemid 37314008)
37. Jobe AH, Ikegami M, Jacobs HC, Jones SJ. Surfactant pool sizes and severity of respiratory distress syndrome in prematurely delivered lambs. Am Rev Respir Dis. 1983;127(6): 751-755
38. Bunt JE, Carnielli VP, Janssen DJ, et al. Treatment with exogenous surfactant stimulates endogenous surfactant synthesis in premature infants with respiratory distress syndrome. Crit Care Med. 2000;28(10):3383-3388
39. Cavicchioli P, Zimmermann LJ, Cogo PE, et al. Endogenous surfactant turnover in preterm infants with respiratory distress syndrome studied with stable isotope lipids. Am J Respir Crit Care Med. 2001;163(1):55-60 (Pubitemid 32095253)
40. Verlato G, Cogo PE, Pesavento R, et al. Surfactant kinetics in newborn infants with pneumonia and respiratory distress syndrome. Ital J Pediatr. 2003;29(11):414-419 (Pubitemid 38235147)